NIVF (NewGenIvf Group) Other Long-Term Liabilities: $-0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NIVF NewGenIvf Group Ltd NIVF
14 GF Score
Price $1.08
! 3 Warning Signs
View Full Analysis

What is NewGenIvf Group Other Long-Term Liabilities?

NewGenIvf Group NIVF -1.82% 14 Other Long-Term Liabilities is $-0.00 Mil as of Dec. 2025. GuruFocus rates NIVF with a GF Score™ of 14/100. The stock has 3 warning signs investors should review.

NewGenIvf Group's other long-term liabilities for the quarter that ended in Dec. 2025 was $-0.00 Mil.

NewGenIvf Group's quarterly other long-term liabilities increased from Jun. 2025 ($-0.00 Mil) to Sep. 2025 ($0.00 Mil) but then declined from Sep. 2025 ($0.00 Mil) to Dec. 2025 ($-0.00 Mil).

NewGenIvf Group's annual other long-term liabilities increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.00 Mil) but then declined from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($-0.00 Mil).

NewGenIvf Group Other Long-Term Liabilities Related Terms

NewGenIvf Group Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for NewGenIvf Group's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NewGenIvf Group Other Long-Term Liabilities Chart

NewGenIvf Group Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
0.00 -0.00 0.00 0.00 -0.00

NewGenIvf Group Quarterly Data
Dec21 Dec22 Jun23 Dec23 Sep24 Dec24 Jun25 Sep25 Dec25
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -0.00 0.00 -0.00
NIVF
14GF Score
NewGenIvf Group Ltd NIVF
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NewGenIvf Group Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $-0.00 Mil mean?
NewGenIvf Group (NIVF) has a Other Long-Term Liabilities of $-0.00 Mil as of Dec. 2025. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on NewGenIvf Group and its competitors.
Is NewGenIvf Group's Other Long-Term Liabilities too high?
NewGenIvf Group's current Other Long-Term Liabilities is $-0.00 Mil. Overall, NewGenIvf Group has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does NewGenIvf Group's Other Long-Term Liabilities compare to CDIX and RHEP?
NewGenIvf Group's Other Long-Term Liabilities of $-0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Healthcare Providers & Services company?
A good Other Long-Term Liabilities depends on the Healthcare Providers & Services industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on NewGenIvf Group and its competitors. NewGenIvf Group's current Other Long-Term Liabilities is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewGenIvf Group stock overvalued right now?
NewGenIvf Group (NIVF) has a current Other Long-Term Liabilities of $-0.00 Mil. The current Other Long-Term Liabilities is $-0.00 Mil. NewGenIvf Group's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For NewGenIvf Group (NIVF), the current Other Long-Term Liabilities is $-0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NewGenIvf Group Business Description

Address Sukhumvit 21 Road, Asoke, 36/39-36/40, 13th Floor, PS Tower, Khlong Toei Nuea Sub-district, Watthana District, Bangkok, THA, 10110
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
14GF Score

Get the complete analysis for NIVF

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.08
Price